{"id":"https://genegraph.clinicalgenome.org/r/53da91f9-ecc3-49ca-83f4-97c57093ed24v1.1","type":"EvidenceStrengthAssertion","dc:description":"There have been few patients presenting with a clinical suspicion of cardiofaciocutaneous syndrome (CFC) carrying a variant in SOS1 (Nystrom et al., 2008; Tumurkhuu et al., 2010). Variable expressivity, age of ascertainment, and outdated clinical assessments of affected individuals may complicate the clinical diagnosis of CFC versus other SOS1-RASopathies. The patients presented in these studies did not have convincing features described and/or there were not strong assertions made to diagnose these individuals with CFC. Therefore, the cases were not scored and the association has been classified as Disputed. Of note, SOS1 has also been classified as definitive in association with Noonan syndrome (NS) and as disputed in association with Costello syndrome. The ClinGen RASopathy Expert Panel found no evidence associating SOS1 with either NS with loose anagen hair or NS with multiple lentigines. This curation was approved by the ClinGen RASopathy Gene Curation Expert Panel on 6/1/18 (SOP Version 5).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/53da91f9-ecc3-49ca-83f4-97c57093ed24","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2021-03-04T20:53:21.546Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2018-06-01T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"no scorable cases.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/978beb92-e693-4bdd-9af0-96bad7f9ca06_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant functionally characterized by Roberts et al. 2007 (17143285). This patient was noted to be atypical for both NS and for CFC. \"He has unusually marked hypertelorism, a very short upturned nose with a wide largetip, and small ears (Fig. 2). He also has clinical featuresthat clearly fit the NS to CFCspectrum,including downslanting of the palpebral fissures, ptosis, a deep philtral groove, and a coarse face. Skin and hair anomalies,including deep palmar creases and dry skin, as well as mental retardation resembled those of CFC patients.\"","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/398b5b2b-25c8-4602-abc1-405c3d3c5a56","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","rdfs:label":"NS211","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"phenotypeFreeText":"pulmonic stenosis; hypertelorism; downslanted palpebral fissures; posteriorly rotated ears; thickened helices; low-set ears; ptosis; thick vermilion border; coarse facial features; deep philtrum; bulbous nose; sparse eyebrow; deep palmar crease; dry skin; moderate global developmental delay; cryptorchidism; short stature; short neck; webbed neck; polyhydramnios; narrow auditory canal","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/978beb92-e693-4bdd-9af0-96bad7f9ca06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","allele":{"id":"https://genegraph.clinicalgenome.org/r/8939978d-82f6-47cc-b031-d793dd37a8be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.2536G>A (p.Glu846Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261734"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b991102e-58a0-4fbd-a763-ac3fdc6c069d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant functionally characterized by Tartaglia et al. 2007 (17143282). \"Phenotype of this patient was between NS and CFC in the early infantile period. He has sparse hair and eyebrows, but this is not that remarkable in a very young child with fair hair. His face is rather large\". THIS CASE WAS COUNTED IN SOS1 NOONAN CURATION AND SHOULD NOT BE COUNTED HERE","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d63e551-0589-41d9-a6af-d3355ce3b4b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","rdfs:label":"NS204","ageType":"AgeAtReport","ageUnit":"Years","ageValue":1,"phenotypeFreeText":"pulmonic stenosis; hypertelorism; downslanted palpebral fissures; posteriorly rotated ears; low-set ears; curly hair; cafÃ©-au-lait spot; delayed skeletal maturation; cryptorchidism; webbed neck; hyperextensibility of the finger joints","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b991102e-58a0-4fbd-a763-ac3fdc6c069d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18651097","allele":{"id":"https://genegraph.clinicalgenome.org/r/92a53c50-481c-4476-b810-9f2e3a4e2c66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1656G>T (p.Arg552Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40684"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a0b1d677-779d-4d97-aa36-043998df65a5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 31 unrelated patients with NS or CFC for variants in RAS genes using dye terminator sequencing. They identified a SOS1 variant in one individual with CFC syndrome. This variant has been seen in multiple other probands with disease (Tartaglia et al. 2007 and Zenker et al. 2007). This patient did not experience mental development, but motor development was affected as well as feeding during infancy.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a321509d-8a5e-4a7d-acc5-109a6e450cb6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18456719","rdfs:label":"Patient 3","phenotypeFreeText":"short stature; motor delay; feeding difficulties in infancy; hypermetropia; ptosis; strabismus; downslanted palpebral fissures; epicanthus; low-set ears; thickened helices; short nose; high, narrow palate; yellow-brown discoloration of the teeth; long philtrum; macrocephaly; bitemporal narrowing; broad neck; pterygium; low posterior hairline;  pectus excavatum; sparse hair; absent eyebrow; dry skin","previousTesting":true,"previousTestingDescription":"Negative for variants in PTPN11","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a0b1d677-779d-4d97-aa36-043998df65a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18456719","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6fcea42-e1b7-490a-904d-0e9eb87dbe27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005633.4(SOS1):c.1297G>A (p.Glu433Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40669"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42aff361-2ac5-44c3-a8f2-0cd0ad0fae12","type":"EvidenceLine","dc:description":"disputed assoication","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bbd213f-0076-43c5-b2e1-25238e0049a3","type":"Finding","dc:description":"This gene is in the RAS/MAPK pathway which is associated with CFC","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23875798","rdfs:label":"SOS1 RAS/MAPK","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ee5b916f-82ef-4738-82c8-46ee2fad131b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38fc059f-aee8-407f-97df-db10607398fd","type":"EvidenceLine","dc:description":"This doesn't provide support for the association just variant pathogenicity","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b28fc59-e68d-4b08-ac6e-341a6b24fcc9","type":"FunctionalAlteration","dc:description":"The variant caused a significant increase in the activation of ERK in the presence of EGF.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712082","rdfs:label":"ERK actiavtion with variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/46516ac2-0e87-4c58-8f93-e091dc107753","type":"EvidenceLine","dc:description":"This study doesn't provide differential support for SOS1's connection with CFC","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32945a8e-8cf2-4d08-8cdf-e1690b4558d5","type":"FunctionalAlteration","dc:description":"The study showed that the M269R, D309Y, R552G, and E846K variants all significantly increased the activation of ERK. The Y337C variant protein was shown to be unstable.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143285","rdfs:label":"SOS1 variants (5)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/21da8c42-fa33-4fb2-973a-4fdffb668916","type":"EvidenceLine","dc:description":"variant pathogenicity not specific to CFC","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e1d24be-9934-4adf-a869-b6251b70e4fa","type":"FunctionalAlteration","dc:description":"They showed that several variants across multiple domains in the protein have significant effects on the protein's function specific to the domains in which the variants are located.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20133692","rdfs:label":"crystal structure of SOS1 protein w/ assays on several varia"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7d81865e-0ced-4c4f-b325-ea68c2744840","type":"EvidenceLine","dc:description":"Doesn't provide differential support for the SOS1 CFC association","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24d2dafd-6868-42ef-8208-fba36531422d","type":"FunctionalAlteration","dc:description":"The R552G variant protein significantly increased the basal level of active RAS and RAS activation after EGF stimulation. The W729L variant constitutively activated RAS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17143282","rdfs:label":"COS1 cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Disputed","sequence":2131,"specifiedBy":"GeneValidityCriteria5","strengthScore":0,"subject":{"id":"https://genegraph.clinicalgenome.org/r/OwLnJExeFYs","type":"GeneValidityProposition","disease":"obo:MONDO_0015280","gene":"hgnc:11187","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}